DR.REDDY'S LABORATORIES

Established Year: 1984
Main Product Category: HEALTH & BEAUTY PRODUCTS Health and Medical Products
Products: Pharmaceutical Products (Generic Formulations, Over-the-Counter Drugs, Biosimilars, Active Pharmaceutical Ingredients)
Brands: OMEZ, NISE, KETOROL, STAMLO, RAZO, CETRINE, CLAMP, ECONORM, ATOCOR, VENUSIA, MINTOP, GLIMY, TELSARTAN
Number of Employees: 19857
Key Executives: Mr. Satish Reddy - Chairman
Mr. G V Prasad - Co-Chairman, Managing Director and Chief Executive Officer
Major Shareholders: Dr. Reddy’s Holdings Limited - 23,32%
Export Markets: United States, European Union countries, Russia, Ukraine, United Kingdom, Venezuela, Brazil, Mexico, Chile, Philippines, Australia, New Zealand, China
Stocks Listed: Stocks of DR.REDDY'S LABORATORIES are listed on National Stock Exchange of India (NSE) under ticker DRREDDY.
Stocks of DR.REDDY'S LABORATORIES are listed on Bombay Stock Exchange (BSE) under ticker 500124.
Stocks of DR.REDDY'S LABORATORIES are listed on New York Stock Exchange (NYSE) under ticker RDY.
Wikipedia: DR.REDDY'S LABORATORIES's page on Wikipedia
Bloomberg: DR.REDDY'S LABORATORIES's profile on Bloomberg
Additional Information:

Dr. Reddy's Laboratories, is an Indian multinational pharmaceutical company based in Hyderabad, Telangana, India.

News and articles related to the company DR.REDDY'S LABORATORIES:

• Dr. Reddy's wins US court respite for generic Suboxone sale
• Dr. Reddy's set to tap $1.9 billion opioid de-addiction US market
• Dr Reddy's Labs forays into Colombia
• Dr Reddy’s Laboratories launches Lamotrigine tablets in US market